LoraRWeiselbergMD

PubMed

• 20 citations
  Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide...
  Elizabeth A. Salerno, Eva Culakova, Amber S. Kleckner, Charles E. Heckler, Po-Ju Lin, Charles E. Matthews, Alison Conlin, Lora Weiselberg, Jerry W. Mitchell, Karen M. ...> ;Journal of Clinical Oncology. 2021 Aug 18
• 14 citations
  The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy.
  Nikesha Gilmore, Supriya G. Mohile, Lianlian Lei, Eva Culakova, Mostafa R. Mohamed, Allison Magnuson, Kah Poh Loh, Ronald J. Maggiore, Elizabeth Belcher, Alison Conlin...> ;Breast Cancer Research. 2021 Feb 5
• 214 citations
  Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longi...
  Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, Kel...> ;Journal of Clinical Oncology. 2017 Feb 10
• 1 citations
  The mammography screening employee inreach program.
  Robinson J, Seltzer, Lawrence L, Autz G, Kostroff K, Weiselberg L, Colagiacomo M> ;The Journal of Reproductive Medicine. 2007 Feb 1
• 11 citations
  A phase I study of sequential vinorelbine followed by paclitaxel
  Daniel R. Budman, Lora Weiselberg, Vivian O'Mara, A. Buchbinder, Stuart M. Lichtman, L. Donahue, L. M. Adams> ;Annals of Oncology. 1999 Jul 1
• Simultaneous strumal ovarii and lymphoma with emphasis on the diagnostic usefulness of immunohistochemical stains.
  M. Nasar Qureshi, Lillian Harvey, Lora Weiselberg, Ellen Kahn> ;Annals of Diagnostic Pathology. 1999 Jun 1
• 5 citations
  Re: Severe Neurotoxicity in Vinorelbine-Paclitaxel Combinations
  Daniel R. Budman, Lora Weiselberg, Vivian O'Mara> ;Journal of the National Cancer Institute. 1997 Jan 1
• 1 citations
  Pharmacokinetic evaluation of zeniplatin in humans
  Linda C. Demarco, Daniel R. Budman, Lathia C, Amorusi P, Birkhofer M, Stuart M. Lichtman, Lora Weiselberg, Vinciguerra, John L. Lovecchio, David Gal> ;Cancer Chemotherapy and Pharmacology. 1995 Jan 1
• 6 citations
  Study of the major phenotype of large granular T-cell lymphoproliferative disorder.
  Tsieh Sun, Judith Brody, Prasad Koduru, Vincent Vinciguerra, Lora Weiselberg, John Marino, Farida Chaudhri, Jean Papps, Robert Erickson> ;American Journal of Clinical Pathology. 1992 Nov 1
• 33 citations
  Use of Cisplatin for Elderly Patients
  Stuart M. Lichtman, Michael Buchholtz, John Marino, Philip Schulman, Steven L. Allen, Lora Weiselberg, Daniel R. Budman, Linda C. Demarco, Michael W. Schuster, John L....> ;Age and Ageing. 1992 May 1
• 22 citations
  Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study.
  Willi Kreis, Daniel R. Budman, K. Chan, Steven L. Allen, Philip Schulman, Lichtman S, Weiselberg L, Michael W. Schuster, J. Freeman, S. Akerman> ;Leukemia. 1991 Nov 1
• 5 citations
  Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
  Stuart M. Lichtman, Daniel R. Budman, Jay Bosworth, Steven G. Allen, Philip Schulman, Lora Weiselberg, Rita Weiss, David Lehrman, Vincent Vinciguerra> ;American Journal of Clinical Oncology. 1991 Aug 1
• 7 citations
  Stereologic analysis of monocytes and their subcellular organelles in patients with acute monocytic and myelomonocytic leukemia.
  Lora Weiselberg, Ursula A. Matulonis, McGarvey E, Roberts B, Stuart M. Lichtman, Allen S, Vinciguerra, Saul Teichberg> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 1990 Sep 1
• 2 citations
  Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule.
  Daniel R. Budman, Willi Kreis, Joanne Behr, Philip Schulman, Stuart M. Lichtman, Steven L. Allen, Lora Weiselberg, W. G. Satterlee, Robert L. Nelson, Vincent Vinciguerra> ;Investigational New Drugs. 1990 Aug 1
• 531 citations
  Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
  Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Robin C. Watson, Nancy L. Geller, Harry W. Herr, Michael J. Morse, Pramod C. Sogani, E. Darracott Vaughan, Neil H. Ban...> ;Cancer. 1989 Dec 15
• 239 citations
  Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
  Zev M. Sthoeger, Mariko Wakai, D B Tse, Vincent Vinciguerra, Steven L. Allen, Daniel R. Budman, Stuart M. Lichtman, Philip Schulman, Lora Weiselberg, Nicholas Chiorazzi> ;The Journal of Experimental Medicine. 1989 Jan 1
• 5 citations
  Pharmacokinetic and Phase I Evaluation of Esorubicin (4′-Deoxydoxorubicin) by Continuous Infusion over Forty-eight Hours in Patients with Leukemia
  Willi Kreis, Cheryl Rottach, Daniel R. Budman, Keith Syson Chan, Philip Schulman, Steven L. Allen, Lora Weiselberg, Vincent Vinciguerra> ;Cancer Research. 1988 Oct 1
• 510 citations
  M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.
  Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Robin C. Watson, Harry W. Herr, Michael J. Morse, Pramod C. Sogani, E. Darracott Vaughan, Neil H. Bander, Lora Weiselb...> ;The Journal of Urology. 1988 Mar 1
• 34 citations
  Effect of Tetrahydrouridine on the Clinical Pharmacology of 1-β-D-Arabinofuranosylcytosine When Both Drugs Are Coinfused over Three Hours
  Willi Kreis, Keith K. H. Chan, Daniel R. Budman, Phillip Schulman, Steven L. Allen, Lora Weiselberg, Stuart M. Lichtman, Vicki Henderson, Jean Freeman, Margaret Deere,...> ;Cancer Research. 1988 Mar 1
• 17 citations
  Pharmacokinetics of Low-Dose 1-β-d-Arabinofuranosylcytosine Given by Continuous Intravenous Infusion over Twenty-one Days
  Willi Kreis, Farida Chaudhri, Keith Syson Chan, Steven G. Allen, Daniel R. Budman, Philip Schulman, Lora Weiselberg, Jean Freeman, Margaret Deere, Vincent Vinciguerra> ;Cancer Research. 1985 Dec 1
• 504 citations
  Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium
  Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Robin C. Watson, Tauseef Ahmed, Lora Weiselberg, Nancy L. Geller, Phyllis Hollander, H Herr, Pramod C. Sogani, Michael...> ;The Journal of Urology. 1985 Mar 1
• 8 citations
  Phase I trial of vinzolidine.
  Daniel R. Budman, Schulman P, M. Marks, Vincent Vinciguerra, Weiselberg L, W. Kreis, Thomas J. Degnan> ;Cancer Treatment Reports. 1984 Jul 1
• 19 citations
  Dysmyelopoietic syndrome: Current concepts
  Thomas J. Degnan, Lora Weiselberg, Philip Schulman, Daniel R. Budman> ;The American Journal of Medicine. 1984 Jan 1
• 19 citations
  Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
  Schulman P, Daniel R. Budman, Weiselberg L, Vinciguerra, Thomas J. Degnan> ;Cancer Treatment Reports. 1983 Oct 1
• 15 citations
  Acquired idiopathic sideroblastic anemia: A new chromosomal abnormality
  Philip Schulman, Nataline B. Kardon, Robert Weiner, Vincent Vinciguerra, Daniel R. Budman, Lora Weiselberg, Thomas J. Degnan> ;Cancer Genetics and Cytogenetics. 1983 Aug 1
• Join now to see all